Equity Brief · Healthcare2026-05-20
DHR·Healthcare

Danaher Corporation

I · KI-Analyse

Kurzfassung

Danaher manufactures specialized equipment and supplies that pharmaceutical companies use to develop and produce drugs, particularly biologics like monoclonal antibodies. They also make diagnostic instruments for hospitals and research labs, along with software and consumables that support the entire drug development lifecycle. The company serves customers in over 60 countries through well-known brands like Beckman Coulter, Leica Microsystems, and Pall.

Danaher is a $118 billion healthcare and life sciences conglomerate that makes equipment, chemicals, and software used by pharmaceutical companies and hospitals [Yahoo Finance]. The company operates through three divisions: Biotechnology (equipment for drug manufacturing), Life Sciences (research instruments and genomics tools), and Diagnostics (hospital testing equipment) [Yahoo Finance]. Despite recent stock underperformance, its core bioprocessing business is recovering strongly with equipment orders up 30%+ as pharma companies expand production capacity [Yahoo Finance].

Solid cash generation with moderate leverage, though profitability metrics show room for improvement

Kurzfassung AI analysisKonfidenz 7/10

Sentinellis-Score

6.3/10

Moderate concerns

Marktkapitalisierung

$118.2B

Umsatz (12 Monate)

$24.6B

II · Aktuelle Nachrichten

Was den Kurs bewegt hat

6 stories · ranked by relevance

  • macro2026-05-20

    Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?

    Yahoo Finance

  • macro2026-05-20

    Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal

    Simply Wall St

  • macro2026-05-19

    Genedata Introduces AI-Native CMC Platform to Accelerate Drug Development and Manufacturing

    Yahoo Finance

  • macro2026-05-18

    Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading

    Yahoo Finance

  • macro2026-05-18

    Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

    Yahoo Finance

  • macro2026-05-17

    Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks

    Yahoo Finance

Premium · kostenlos mit jedem Konto

The stock has fallen 27% in 2026 following multiple weak quarterly earnings reports, significantly underperforming the S&P 500's 27% gain over the past year [Yahoo Finance]

1 von 5 Risiken in diesem Bericht

Risiken

5

Chancen

7

Warnsignale

3

Führung

10

24 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.

Vollständige Danaher Corporation-Analyse freischalten

Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.

  • 5 Risiken, 7 Chancen und 3 Warnsignale — jeweils mit Quelle
  • Über 100 Finanzkennzahlen mit Charts und Vergleichen
  • Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
  • Führungsteam und Vergütung
  • PDF-Export für offline
Alle 15 Erkenntnisse freischalten3 kostenlose Berichte · keine Karte

III · Ähnliche Unternehmen

Das könnte Sie auch interessieren

Same sector · Healthcare or comparable health

Auf Ihre Watchlist setzen?

Read three companies free. Keine Karte.

3 kostenlose Berichte sichern